Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration

Authors

Maud Gratuze, Washington University School of Medicine in St. Louis
Cheryl Eg Leyns, Washington University School of Medicine in St. Louis
Andrew D Sauerbeck, Washington University School of Medicine in St. Louis
Marie-Kim St-Pierre, University of Victoria
Monica Xiong, Washington University School of Medicine in St. Louis
Nayeon Kim, Washington University School of Medicine in St. Louis
Javier Remolina Serrano, Washington University School of Medicine in St. Louis
Marie-Ève Tremblay, University of Victoria
Terrance T Kummer, Washington University School of Medicine in St. Louis
Marco Colonna, Washington University School of Medicine in St. Louis
Jason D Ulrich, Washington University School of Medicine in St. Louis
David M Holtzman, Washington University School of Medicine in St. Louis

Journal

The Journal of Clinical Investigation

Publication Date

2020

Volume

130

Issue

9

First Page

4954

Last Page

4968

Document Type

Open Access Publication

DOI

10.1172/JCI138179

Rights and Permissions

Gratuze M, Leyns CE, Sauerbeck AD, et al. Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration. J Clin Invest. 2020;130(9):4954-4968. doi:10.1172/JCI138179

Recommended Citation

Gratuze, Maud; Leyns, Cheryl Eg; Sauerbeck, Andrew D; St-Pierre, Marie-Kim; Xiong, Monica; Kim, Nayeon; Serrano, Javier Remolina; Tremblay, Marie-Ève; Kummer, Terrance T; Colonna, Marco; Ulrich, Jason D; and Holtzman, David M, "Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration." The Journal of Clinical Investigation. 130, 9. 4954 - 4968. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9360